7 studies were found.

1.		No longer recruiting	Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
2.		No longer recruiting	Study of T900607-sodium in chemotherapy naive patients with hepatocellular carcinoma. Condition: Hepatocellular Carcinoma
3.		Terminated	Study of T900607-sodium in previously treated patients with non-Hodgkin's lymphoma. Condition: Non-Hodgkin's Lymphoma
4.		No longer recruiting	Study of T900607-sodium in previously treated patients with ovarian cancer. Condition: Ovarian Neoplasms
5.		Suspended	Study of T900607-sodium in subjects with previously treated gastric cancer or adenocarcinoma of the esophagus Conditions: Gastric Cancer; Esophageal Neoplasms
6.		No longer recruiting	T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
7.		Terminated	T138067 versus doxorubicin in chemotherapy-naive, unresectable, hepatocellular carcinoma patients Condition: Hepatocellular Carcinoma